Caldwell & Orkin’s Boeing BA Stock Holding History

Caldwell & Orkin’s Portfolio BA Stock Details BA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-42,030	Closed	-$5.35M	–	65
2014 Q2	$5.35M	Buy	42,030 +37,000	+736%	+$4.83M	2.71%	4
2014 Q1	$631K	Sell	5,030 -27,170	-84%	-$3.54M	0.41%	60
2013 Q4	$4.39M	Buy	32,200 +5,800	+22%	+$754K	2.38%	14
2013 Q3	$3.1M	Buy	+26,400	New	+$2.84M	1.82%	24

Other funds holding BA

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ETC

Evercore Trust Company New York $34.6B AUM 25.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Caldwell & Orkin's BA Position: Q3 2014 in Review

Caldwell & Orkin sold out of Boeing (BA) in Q3 2014, closing a stake of 42,030 shares — an estimated $5.35M sold.

Caldwell & Orkin first reported a position in BA in Q3 2013 and held it in 4 quarters. The position peaked at $5.35M in Q2 2014. 1,167 funds tracked by Wall St. Rank hold BA as of Q3 2014.

Caldwell & Orkin reported no remaining Boeing position as of Q3 2014 after selling out during the quarter.
Caldwell & Orkin sold 42,030 Boeing shares in Q3 2014, an estimated $5.35M.
Caldwell & Orkin first reported a position in Boeing in Q3 2013 and held it in 4 quarters.
Caldwell & Orkin's Boeing position peaked at $5.35M in Q2 2014.
1,167 funds tracked by Wall St. Rank held Boeing as of Q3 2014.

Based on Caldwell & Orkin's 13F filing for Q3 2014, filed 10 Nov 2014.